A comparative observation on regenerative nodules, altered hepatocyte nodules and hepatocellular carcinomas
10.3760/cma.j.issn.1006-9801.2011.03.001
- VernacularTitle:肝细胞再生结节、变异肝细胞结节与肝细胞癌之间的对照观察
- Author:
Xiaoying TENG
;
Yiran CAI
;
Lei GUO
;
Qin SU
- Publication Type:Journal Article
- Keywords:
Carcinoma,hepatocellular;
Regenerative nodule;
Nodule of altered hepatocytes
- From:
Cancer Research and Clinic
2011;23(3):145-149
- CountryChina
- Language:Chinese
-
Abstract:
Objective To describe the development of nodules of altered hepatocytes (NAH) in chronic hepatitis B and to reveal progression of the nodules to hepatocellular carcinoma (HCC). Methods HCC, NAH and ordinary regenerative nodules (ORN) were identified and compared histologically. Expression levels of hepatitis B virus (HBV) antigens, mitoactivity and p53 accumulation in these lesions were evaluated by immunohistochemistry. Results Multiple foci of altered hepatocytes (FAH) and NAH were identified in the liver parenchyma surrounding HCC in all of the samples examined. Sequential architectural and cellular changes were observed during the progression of FAH to NAH and HCC. Expression levels of HBV surface and core antigens were found to be significantly decreased in ORN, NAH and HCC, with their positive rates being 70 % (35/50), 50 % (25/50), 10 % (5/50) and 60 % (30/50), 40 % (20/50), 6 % (3/50), respectively (P <0.05). Ki-67-1abelling indices were determined to be (0.58±0.49) %, (2.46±1.05) % and (40.36±26.27) %in these lesions, respectively (P <0.05). Nuclear p53 accumulation was found only in HCC. Its occurrence was associated to a high histological grade, with its frequencies being 13 % (1/8), 41% (11/27) and 73 % (11/15)in grade 1, 2 and 3 lesions, respectively. Conclusion NAH lesions, identified by their morphologic features and mitoactivity elevation, are detectable in resected liver samples with chronic hepatitis B and cirrhosis. They represent a common HCC precursor and can be used as a surrogate marker for the surveillance of high-risk individuals.